$TDOC News

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

TDOC Q2 Deep Dive: Cash Pay Decline and Insurance Shift Pressure Guidance

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

Are Investors Undervaluing Teladoc Health (TDOC) Right Now?

Teladoc Health (TDOC) Could Be 56% Undervalued As Weak Results Reset Expectations

Teladoc (TDOC) Stock Plummets on Disappointing Q2 Earnings Results

Teladoc Health, Inc. Q2 2026 Earnings Call Summary

Teladoc Health Q2 Earnings Call Highlights

Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

Teladoc lowers revenue outlook amid BetterHelp demand headwinds

Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook

Teladoc Health, Inc. (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health, Inc. 2026 Q2 - Results - Earnings Call Presentation

Teladoc Health (NYSE:TDOC) Plunges After Revenue Miss and Weak Guidance

Why Teladoc Stock is Getting Crushed Wednesday After Hours

Teladoc Health Sees Q3 GAAP EPS $(0.30)-$(0.20) vs $(0.18) Est; Sees Sales $569.000M-$609.000M vs $629.252M Est

Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) Est; Lowers FY2026 Sales Guidance from $2.481B-$2.576B to $2.362B-$2.447B vs $2.508B Est

Teladoc Health Q2 EPS $(0.21) Beats $(0.25) Estimate, Sales $606.927M Miss $615.391M Estimate